Testing effectiveness (Phase 2)Looking for participantsNCT05377996
What this trial is testing
Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Who this might be right for
Triple Negative Breast CancerBreast CancerEndometrial Cancer+4 more
Day One Biopharmaceuticals, Inc. 360